SMAD3 and disease arising from reactivation of latent virus: We have previously identified SMAD3 as a target of the HCMV miRNAs miR-UL22A-5p and -3p, and have shown that miR-UL22A-mediated reduction of SMAD3 is required for genome maintenance during latent infection [9].